Work

Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer

Year: 2014

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-014-3042-3

Authors: Vakaramoko Diaby, Georges Adunlin, Simon B. Zeichner, Kiran Avancha, Gilberto Lopes, Stefan Gluck, Alberto J. Montero

Institutions: Florida Agricultural and Mechanical University, Mount Sinai Medical Center, Hartford Hospital, Johns Hopkins University, University of Miami, Sylvester Comprehensive Cancer Center

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute on Minority Health and Health Disparities

Awards: Center of Excellence for Cancer Research, Training and Community Service, FAMU RCMI Pharmaceutical Research Center

OpenAlex ID: W1991721331

FWCI: 6.631

Cites: 20

Cited by: 19

Related to: 10